Travatan (Travoprost) - Summary

TRAVATAN SUMMARY

Travatan®
travoprost ophthalmic solution 0.004%
Sterile

Travoprost is a synthetic prostaglandin F_2(alpha) analogue.

TRAVATAN® Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.

See all Travatan indications & dosage >>

TRAVATAN NEWS HIGHLIGHTS

Published Studies Related to Travatan (Travoprost)

Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. [2008.05]

Duration of IOP reduction with travoprost BAK-free solution. [2008.04]

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%. [2008.04]

A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients. [2008]

A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. [2007.09]

more >>

Clinical Trials Related to Travatan (Travoprost)

Study of Patient Use and Perception of the Travatan Dosing Aid [Completed]

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [Completed]

Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy [Completed]

24-Hour IOP Control With TTFC vs Travoprost When Both Are Given PM in Subjects With POAG [Completed]

Safety and IOP Lowering Efficacy of AL-6221 [Active, not recruiting]

more >>